J. Vial

发表

Adverse drug events as a cause of hospital admission in the elderly

M. Chan, F. Nicklason, J. Vial, 2001, Internal medicine journal.

Review of management of type 2 diabetes mellitus

G. Peterson, J. Vial, W. Yap, 1998, Journal of clinical pharmacy and therapeutics.

Doctors’ beliefs on the use of antithrombotic therapy in atrial fibrillation: identifying barriers to stroke prevention

S. Jackson, G. Peterson, G. Peterson, 2002, Internal medicine journal.

Hypertension Management Guide for Doctors 2004

G. Hankey, I. Puddey, A. Dart, 2004 .

Comparison of Cyclooxygenase Inhibition with Two Different Doses of Enteric Coated Aspirin in Normal Young and Elderly Subjects and Elderly with Cerebrovascular Disease

J. Vial, C. Narkowicz, 1995 .

Educational campaign to improve the prevention of postoperative venous thromboembolism

G. Peterson, J. Vial, S. Wilkinson, 1999, Journal of clinical pharmacy and therapeutics.

Ipratropium Treatment of Acute Airways Disease

G. Peterson, J. Vial, M. Bleasel, 2003, The Annals of pharmacotherapy.

Outcomes in the management of atrial fibrillation: clinical trial results can apply in practice

S. Jackson, G. Peterson, G. Peterson, 2001, Internal medicine journal.

DELAYED RECOVERY FROM NG‐NITRO‐L‐ARGININE IN THE CONSCIOUS SHEEP

J. Vial, Christian K. Narkowic, Xiao F. Xu, 1991, Clinical and experimental pharmacology & physiology.

Inhibition of platelet function by a controlled release acetylsalicylic acid formulation — Single and chronic dosing studies

M. Roberts, J. Vial, M. S. Roberts, 2004, European Journal of Clinical Pharmacology.

Inhibition of platelet function by a controlled release acetylsalicylic acid formulation — Single and chronic dosing studies

M. Roberts, J. Vial, P. Cossum, 2004, European Journal of Clinical Pharmacology.

Selective inhibition of platelet cyclooxygenase with controlled release, low-dose aspirin.

J. Vial, M. S. Roberts, P. Seville, 1990, Australian and New Zealand journal of medicine.

Urinary Prostanoid Metabolites and Serum Thromboxane Following Recovery from Cyclooxygenase Inhibition with Aspirin

J. Vial, C. Narkowicz, 1995 .

Rebound elevation in urinary thromboxane B2 and 6-keto-PGF1 alpha excretion after aspirin withdrawal.

J. Vial, M. S. Roberts, L. J. Mcleod, 1991, Advances in prostaglandin, thromboxane, and leukotriene research.

Improving the outcomes of anticoagulation in rural Australia: an evaluation of pharmacist‐assisted monitoring of warfarin therapy

S. Jackson, G. Peterson, J. Vial, 2005, Journal of clinical pharmacy and therapeutics.

Rural and Remote Pharmacy Workforce Development Program

S. Jackson, G. Peterson, J. Vial, 2004 .

Hyperbaric oxygen therapy increases free radical levels in the blood of humans.

J. Vial, C. Narkowicz, P. McCartney, 1993, Free radical research communications.

CONTENTS

H. Krum, L. Teh, R. Ferner, 2004 .

Impact of pharmacist‐conducted home visits on the outcomes of lipid‐lowering drug therapy

H. Krum, G. Peterson, J. Vial, 2004, Journal of clinical pharmacy and therapeutics.

Accuracy and clinical usefulness of the near-patient testing CoaguChek S international normalised ratio monitor in rural medical practice.

S. Jackson, G. Peterson, J. Vial, 2004, The Australian journal of rural health.

Accuracy, reproducibility and clinical utility of the CoaguChek S portable international normalized ratio monitor in an outpatient anticoagulation clinic.

S. Jackson, G. Peterson, J. Vial, 2004, Clinical and laboratory haematology.

Nonsteroidal antiinflammatory drugs in rheumatoid arthritis and osteoarthritis: support for the concept of "responders" and "nonresponders".

R. Day, J. Vial, J. Walker, 1997, Arthritis and rheumatism.

Effect of vasoactive peptides on prostacyclin synthesis in man

C. Dollery, J. Ritter, J. Vial, 1986, British journal of pharmacology.

Undertreatment of congestive heart failure in an Australian setting

G. Peterson, J. Vial, M. Bleasel, 2004, Journal of clinical pharmacy and therapeutics.

Community-based educational intervention to improve antithrombotic drug use in atrial fibrillation

S. Jackson, G. Peterson, J. Vial, 2003 .

PREVENTION OF STRUCTURAL ARTERIOLAR CHANGES IN DOCA HYPERTENSION WITH HYDRALLAZINE

J. Vial, G. W. Boyd, A. Yong, 1983, Clinical and experimental pharmacology & physiology.

Histometric assessment of renal arterioles during DOCA and post-DOCA hypertension and hydralazine treatment in rats.

J. Vial, G. W. Boyd, 1989, Journal of hypertension.

SLOW-RELEASE ASPIRIN AND PROSTAGLANDIN INHIBITION

R. M. Joyce, J. Vial, M. S. Roberts, 1986, The Lancet.

Naproxen concentrations in plasma and synovial fluid and effects on prostanoid concentrations.

R. Day, K. Williams, J. Vial, 1996, The Journal of rheumatology.

The effects of different doses of some acetylsalicylic acid formulations on platelet function and bleeding times in healthy subjects.

M. Roberts, J. Vial, P. Cossum, 2009, Scandinavian journal of haematology.

Improving Clinical Outcomes for Hospital Patients Initiated on Warfarin

S. Jackson, G. Peterson, J. Vial, 2007 .

Improving the outcomes of anticoagulation: an evaluation of home follow‐up of warfarin initiation

S. Jackson, G. Peterson, J. Vial, 2004, Journal of internal medicine.

A Community-Based Educational Intervention to Improve Antithrombotic Drug Use in Atrial Fibrillation

S. Jackson, J. Vial, Gregory M. Peterson, 2004, The Annals of pharmacotherapy.

1999 Guide to Management of Hypertension for Doctors

Janet H. Vial, Graeme J. Hankey, G. Hankey, 1999 .

ONSET AND OFFSET OF STRUCTURAL ARTERIOLAR CHANGES IN DOCA/SALT HYPERTENSION IN THE RAT

J. Vial, G. W. Boyd, A. Yong, 1982, Clinical and experimental pharmacology & physiology.

Effect ofvasoactive peptides on prostacyclin synthesis

J. Vial, 1986 .